Brain Cancer

What does that mean? I passed my cologuard but have only seen a few hummingbirds in my garden- I got it I have glioblastoma. (@Prakman_2_in_2d)

She’s a female ( more liable to meningioma d2 high estrogen receptors ) Her young age suggests meningioma Presence of calcifications Most probably the answer is B (@asma_ashraf63)

This is lorlatinib for pediatric brain cancer (at least that is my impression) neo adjuvant. We don't know the mutational profile of the child. I doubt any country in Europe would cover it. It's not lorlatinib for nsclc with alk. (@VPrasadMDMPH)

Yes. This is not even that. This is lorlatinib for ped brain cancer prior to resection. And mutations not given. Lorlatinib has more data for nsclc w alk and brain Mets. (@VPrasadMDMPH)

A major thanks to @EliasatDell and to @MDAndersonNews @fredericklangMD @VPuduvalli for joining forces to advance brain tumor research & helping patients through the power of philanthropy and science working together. (@dfarons)

Awesome viewpoint by @MattCarlsonMD @MichaelJLinkMD. Paradigm shifting work in how we manage vestibular schwannomas https://t.co/fSwwBc5KN6 (@tmcrackan)

Today is Glioblastoma Awareness Day! @PatrickHwuMD discusses why glioblastoma is so tough to treat and why research and clinical trials are needed for this aggressive disease. (@MoffittNews)

Kind of crazy that @michelle_monje has given 3 independent talks at the @CancerNeurosci1 conference on 3 different research avenues tackling brain development, plasticity, paracrine signaling in brain cancer, and treatment-related side effects!...all while zooming in at midnight! (@JBorniger)

I love this line of thinking! Critical to include brain tumors like #GBM into the discussion as well. Most novel therapies have only made incremental gains in survival. Critical to include patients' voice re impact of these therapies #btsm @WeTrialshub (@DrAMansouri)

"...will be travelling to London very soon to hopefully avail of the first administration of the life prolonging vaccine - DCVAX - L." 👏👏👏 The DCVax® Platform For All Solid Tumor Cancers $nwbo #dcvax #glioblastoma #CancerMoonshot @POTUS @NCIDirector https://t.co/tQIP24h5ki (@sharpie510)

🧠Leptomeningeal metastasis (LM). Ph2 RCT: protonCSI 🆚 photon WBRT &/or involved field (IFRT) @JYangMDPhD et al. PMID: 35802849 LM: 1) >common ass: Lung & breast 2)🚫Dismal prognosis (wks) ⚡️pCSI (30Gy/10f) ⬆️PFS 7.5m vs 2.3m (ss) ⬆️OS 9.9m vs 6m (ss) 🟰ToxG3/4 #BrainTumor (@larosa_rosa3)

Manmeet S. Ahluwalia, MD, a Q2 2023 Oncology Icons honoree, looks back on the career moves that led him to this award, including his work at @ClevelandClinic, the @ASCO Leadership Development Program, & @BaptistHealthSF. | @BrainTumorDoc https://t.co/OsSRX3u3D2 (@TargetedOnc)

Thank you, @AAPIUSA, for championing #IPV awareness & sparking collaboration on #DomesticViolence Excited to unite across disciplines and work together for a lasting change @HarvardTIRIC @NinaVasan @BrainTumorDoc #DVawareness #SouthAsian (@KhuranaBharti)

Thank you @BrainTumorDoc so much! I really hope we expand our work to collaborate with you in supporting patients with brain metastasis. (@NaglaAKarimMD)

Today @ProfGLongMIA and I talked to Ray Hadley about my #glioblastoma diagnosis and applying some of the lessons learnt in melanoma treatment to brain cancer. Watch and listen to our discussion via the link https://t.co/qjsFvWYJ3M @2GB873 @HadleyRayhadley (@ProfRScolyerMIA)

What an incredible discussion! I’m in awe of your bravery @ProfRScolyerMIA and hope the treatments you are trying are successful. This is so inspiring for those of us impacted by #braintumours ❤️ (@HayleyBetts7)

Dear Prof,you are an inspiration.A man of dedication,innovation, humility & courage🙏your years of research,& team advances of Rx melanoma can be extrapolated &lead to improved prognosis,quality of life, &life expectancy for you, & all who suffer this cruel disease Glioblastoma x (@kym83810679)

I lost my beautiful daughter Amani last year to glioblastoma , an utterly devastating disease. I hope the work you do will bring real change with more effective treatment options. (@Khuram1972)

Extraordinary paper, discussed at @DoctorQMd lab meeting illustrating the impact of remote neural activity in glioma infiltration. @michelle_monje @DoctorGRao https://t.co/FSEZO5iCUQ (@diogo_mgarcia)

Excited to start the NCI Interprofessional Communications Curriculum Course #NCI #ICCCourse2023 with the formidable @Tsarmstrong01 @NCIResearchCtr @NIHBrainTumor @nciccr_gmb @gulleyj1 #PatientCare (@FatimaKarzai)

https://t.co/pK1OxY7uyP @whereisdaz @WEHI_research @cancerNSW @PCFnews @PeterMacCC @Cancer_Research @KidsCancerInst @AzadOncology @myESMO @FDAOncology @JCO_ASCO @NIHBrainTumor (@MaccaPolitical)

ASCI member Timothy A. Chan @GeneCollector @ClevelandClinic in @JCI_insight: Germline SNP promotes an immune active microenvironment in glioblastoma: https://t.co/uODHtf8NxZ #Immunology #Oncology (@the_asci)

Having a gorgeous friend who has undergone multiple “radical” but lifesaving brain cancer surgeries (thanks Dr Charlie Teo), my heart exploded and my tears erupted watching your interview tonight. You’ve got this! (@ShellTaylor8)

I feel incredibly fortunate & grateful 2 b supported by amazing/inspirational @ProfGLongMIA & a superb multidiscipl neuro-onc team in treatment of my #WHO Grade 4 #glioblastoma (IDH WT & multiple adverse molec prog features). Here’s a brief update on my treatment journey so far! (@ProfRScolyerMIA)

Professor: my sons friends wife had glioblastoma as a child she battled it a long time got treatment at City of Hope she is still alive and in her 30's now!!! Hope!!! (@Abbeyandsmokey)

I hope so professor! I don't have the knowledge you have but I am feeling a lot of hope lately with articles I am reading I keep praying the researchers are going to find a cure for glioblastoma and metastatic Ocular melanoma to liver! Hope! (@Abbeyandsmokey)

My lab works on brain metastatic melanoma and glioblastoma. We are trying hard to find treatments that work for both. While we’ve had success in melanoma, glioblastoma has been very challenging. We now have preclinical models of all molecular subtypes and we will keep trying! (@HolmenSheri)

Having had my life impacted by glioblastoma with the death of my husband, I hope for the best from this - personally for yourself - but also for other current and future patients. Thank you. (@JennyMc79436338)

#Immunotherapy ♂♀ | #Sex-Biased #Exhaustion of #Tcells Drives Differential Responses to #ImmuneCheckpointInhibition in #Glioblastoma 🧠 | Great work @JustinLathia & Co. now @CD_AACR @AACR | https://t.co/9l8Icbch1g (@profcelentyx)

Congratulations to my wonderful friend @BrainTumorDoc A very well deserved honor. I am so proud of you. May your success continue. (@NaglaAKarimMD)

Secretory meningioma (@BarathiNataraj)

Perineuronal satellitosis! (There is something about those pontine neurons that gliomas are so drawn to….) (@michelle_monje)

Microcystic Meningioma? (@vaghasiyaviren)

Chordoid meningioma.Smarce1 mutation. (@ArchanabAol27)

This is psamomatous meningioma (@ibo_dimma)

Secretory meningioma (@Nisha81472187)

This is actually a microcystic meningioma. Thin-walled structures containing grungy proteinaceous pink stuff, not dense reddish material (secretory) or RBCs (angiomatous). Gain of chromosome 5 is common. Great guesses, everyone! (@CraigHorbinski)

secretary meningioma (@NewjobiRakesh)

#FeatureFriday Today on #FeatureFriday, we are featuring a tweet by Dr. Vivek Subbiah [@VivekSubbiah]on a recent discovery that was made after a decade-long investigation into the relationship between Papillary Craniopharyngiomas and the BRAF mutation. #MedTwitter (@4baseCare)

Excited to share our analysis of 3,600 “real world” cases of Small Cell Lung Cancer (SCLC) – @christine_lovly #cancer #brainmetastases #lungcancer #mutations #realworld #tumors #oncology #oncodaily https://t.co/ihtdnq3tie (@oncodaily)

I cocked up a meningioma in my exam. (called it craniopharingioma) Marked as wrong but not dangerous. (I suck on neuropath) (@daninava)

Secretory meningioma! KLF4 and TRAF7 mutations. (@nusrat_xahra)